Augmedix Inc
NASDAQ:AUGX
Augmedix Inc
NASDAQ:AUGX
Price:
2.89 USD
1.4%
Updated:
Apr 29, 2024
Augmedix Inc
Cash from Financing Activities
|
Augmedix Inc
Cash from Financing Activities Peer Comparison
Comparables:
VEEV
INSP
EVH
DOCS
GDRX
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Augmedix Inc
NASDAQ:AUGX
|
Cash from Financing Activities
$43.4m
|
CAGR 3-Years
18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cash from Financing Activities
-$16.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash from Financing Activities
$14m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
Evolent Health Inc
NYSE:EVH
|
Cash from Financing Activities
$281.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Cash from Financing Activities
-$74.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Cash from Financing Activities
-$167.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
See Also
What is Augmedix Inc's Cash from Financing Activities?
Cash from Financing Activities
43.4m
USD
43.4m
USD
Based on the financial report for Dec 31, 2023, Augmedix Inc's Cash from Financing Activities amounts to 43.4m USD.
What is Augmedix Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
14%
14%
The average annual Cash from Financing Activities growth rates for Augmedix Inc have been 18% over the past three years , 14% over the past five years .
You don't have any saved screeners yet
